Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels
Noon & Night Introducing Noon & Night, featuring Lavender Fizz bath bombs and Omega CBD Soft Gels. TORONTO, April 13,...
Noon & Night Introducing Noon & Night, featuring Lavender Fizz bath bombs and Omega CBD Soft Gels. TORONTO, April 13,...
PRESS RELEASE Antion Biosciences to Present at Upcoming Scientific Conferences - Abstract acceptance at the American Society of Gene &...
MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response...
Post hoc analysis showed a 46% decrease in mean lesion growth in eight patients with bilateral GA comparing treated eye...
Toronto, Ontario--(Newsfile Corp. - April 13, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the...
Senior Executive with vast CPG Experience to Lead Sales Function, Driving Growth for the Rritual product line throughout USAVancouver, British...
Leading home healthcare provider Intrepid USA leverages WellSky’s new predictive data analytics capabilities for enhanced visit utilization management OVERLAND PARK,...
SAN FRANCISCO--(BUSINESS WIRE)--Bodyport, the digital health company focused on the detection and management of heart disease, today announced that it...
Expanding capabilities to personal devices provides greater options for all patients and reduces costs for providers BETHESDA, Md.--(BUSINESS WIRE)--#CareToBeGreat--GetWellNetwork, a...
Company Expands Vascular Reach to Treat Unmet Needs of Both AAA and PAD Patients IRVINE, Calif.--(BUSINESS WIRE)--#AAA--Endologix LLC, a leader...
Report by GigCX platform provider Limitless shows customer service has helped supplement ‘gigger’ income and had a positive impact on...
beLAB2122 LEVERAGES ACADEMIC INNOVATION FROM THE RHINE-MAIN-NECKAR REGION OF GERMANY EVOTEC PROVIDES ITS ALL-MODALITY PLATFORM TO VALIDATE FIRST-IN-CLASS THERAPEUTIC PROJECTS...
TAIPEI, TAIWAN / ACCESSWIRE / April 13, 2021 / Bened Biomedical’s psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a...
Randomized, Placebo-Controlled Phase 2 Study for Swiss Biotech Kinarus' Orally Administered Lead Candidate KIN001 in Hospitalized COVID-19 Patients First Interim...
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021...